Furthermore, although we conducted preliminary validation of the functionality of CD44+ tumour cells, the roles of the key signal SPP1 and its upstream transcriptional regulatory mechanisms, as well as downstream signalling transduction mechanisms, lack validation through in vivo and in vitro experiments. The gene discussed is CD44; the disease is neoplasm.